is tirzepatide a glp-1 agonist Dual and Triple Gut Peptide Agonists on the Horizon for the Treatment of Type 2 Diabetes and Obesity. An Overview of Preclinical and Clinical Data Semaglutide vs. Tirzepatide: Which GLP-1

doi: 10.1111/dom.13741 53 MehrtashFDushayJMansonJE

In toxin-induced rodent models of PD (MPTP, 6-OHDA, rotenone, LPS), exendin-4 (142145), liraglutide (146, 147), lixisenatide (146), and semaglutide (57, 148) reduced dopaminergic neuron loss, preserved striatal terminals, and improved motor performance, in association with stabilization of mitochondria, reduced oxidative stress, and reduced inflammation

Supplementary Information The online version contains supplementary material available at 10.1186/s13098-025-01712-w

A 2023 study published in the Journal of Hepatology reported on a Phase IIa trial aimed at evaluating the efficacy and safety of efinopegdutide in patients with NAFLD, comparing it to semaglutide

In the periphery, GLP-1 is released from the gut in response to the presence of food nutrients

Innate immunity in Alzheimers disease